ISA 2020 | Tocilizumab for AA Amyloidosis

Anti-interleukin-6 receptor, tocilizumab, has demonstrated improvements in the clinical symptoms of patients with AA amyloidosis, being associated with regression of amyloid deposition. Luis Quintana, MD, PhD, Hospital Clínic de Barcelona, Barcelona, Spain discusses the use of this agent for AA amyloidosis.

Stay Up To Date:

Receive the latest news and developments in treatment and care

Featured Resources

FAQs

1 The Core Members of an Amyloidosis Care Team ?

Find resources, support groups, and organizations that offer information, assistance, and a community for Amyloidosis patients and their families.

2 What Treatment Options are Available for Amyloidosis?

Find resources, support groups, and organizations that offer information, assistance, and a community for Amyloidosis patients and their families.

3 How is Amyloidosis Diagnosed?

Find resources, support groups, and organizations that offer information, assistance, and a community for Amyloidosis patients and their families.

4 What Specialists Are Involved in the Treatment of Amyloidosis?

Find resources, support groups, and organizations that offer information, assistance, and a community for Amyloidosis patients and their families.

Patient Care Center

ISA 2020 | Tocilizumab for AA Amyloidosis

Stay Up To Date:

Featured Resources

Caregiver Support : Taking care of yourself

Caregiver Support : Taking care of yourself

FAQs

Patient Affair Directory

Video Library